{"id":219448,"date":"2026-08-26T10:56:37","date_gmt":"2026-08-26T05:26:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=219448"},"modified":"2026-08-26T10:56:37","modified_gmt":"2026-08-26T05:26:37","slug":"why-sequent-scientific-share-price-price-fall-2026-08-26","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/","title":{"rendered":"Sequent Scientific (VIYASH) Share Price falls 5.18% to Rs 263.8; what moved the stock today"},"content":{"rendered":"<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;26 August 2026 at 10:54:39 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Sequent Scientific fell to Rs 263.8, down 5.18% today, with a market capitalisation of Rs 11,998.48 crore. The move keeps the stock in focus for readers tracking price action, valuation and sector context.<\/p>\n<p>Sequent Scientific Share Price declined from Rs 278.2 at the previous close to Rs 263.8 in the latest session. The day change was Rs -14.4, equal to -5.18%, and the company\u2019s market capitalisation stood at Rs 11,998.48 crore. The supplied data confirms the move, but it does not identify a company-specific catalyst, so the decline should be read as a verified market event rather than a named-news reaction.<\/p>\n<p>The session opened at Rs 271, touched an intraday high of Rs 271.35 and a low of Rs 262.4, and finished close to the day\u2019s bottom. Turnover was Rs 197.93 crore. Sequent Scientific is tagged as a Mid Cap in the supplied data, which gives size context but does not explain the fall. For investors reading the stock news update, the key point is that the price action is real and measurable, while the trigger remains unspecified in the provided information.<\/p>\n<p>That makes the latest move a matter of stock analysis, not speculation. The available numbers allow a grounded look at the session, the valuation profile and the broader healthcare benchmark. Readers searching for Sequent Scientific Latest News or Sequent Scientific Share News can rely on the verified figures below.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Sequent_Scientific_VIYASH_Share_Price_Today_Price_Action_Analysis\" title=\"Sequent Scientific (VIYASH) Share Price Today: Price Action Analysis\">Sequent Scientific (VIYASH) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Sequent_Scientific_VIYASH_Fundamental_Analysis\" title=\"Sequent Scientific (VIYASH) Fundamental Analysis\">Sequent Scientific (VIYASH) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Why_Investors_Are_Watching_Sequent_Scientific\" title=\"Why Investors Are Watching Sequent Scientific\">Why Investors Are Watching Sequent Scientific<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#About_Sequent_Scientific\" title=\"About Sequent Scientific\">About Sequent Scientific<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Track_Sequent_Scientific_Share_Price_on_Univest\" title=\"Track Sequent Scientific Share Price on Univest\">Track Sequent Scientific Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Why_did_Sequent_Scientific_Share_Price_fall_today\" title=\"Why did Sequent Scientific Share Price fall today?\">Why did Sequent Scientific Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#What_is_Sequent_Scientific_Share_Price_Today\" title=\"What is Sequent Scientific Share Price Today?\">What is Sequent Scientific Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#What_do_the_valuation_metrics_show_for_Sequent_Scientific\" title=\"What do the valuation metrics show for Sequent Scientific?\">What do the valuation metrics show for Sequent Scientific?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#How_does_Sequent_Scientific_compare_with_sector_benchmarks\" title=\"How does Sequent Scientific compare with sector benchmarks?\">How does Sequent Scientific compare with sector benchmarks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#How_does_Sequent_Scientific_compare_with_peers\" title=\"How does Sequent Scientific compare with peers?\">How does Sequent Scientific compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-sequent-scientific-share-price-price-fall-2026-08-26\/#Should_investors_track_Sequent_Scientific_Share_Price_on_Univest\" title=\"Should investors track Sequent Scientific Share Price on Univest?\">Should investors track Sequent Scientific Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sequent_Scientific_VIYASH_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Sequent Scientific (VIYASH) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 263.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 278.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 14.40 (-5.18%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 271<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 271.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 262.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 197.93 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 11,998.48 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock opened below the previous close and stayed under that level for the full session. Its high of Rs 271.35 was only slightly above the open, while the low of Rs 262.4 sat very close to the closing price. That tight finish near the low shows a session that ended under pressure, even though the trading range itself was not wide.<\/p>\n<p>On a simple price basis, Sequent Scientific Share Price lost Rs 14.4 in one day. The combination of a lower close, a modest intraday band and turnover of Rs 197.93 crore makes the session notable for market-watchers scanning top decliners. The supplied data confirms the move, but not a direct catalyst.<\/p>\n<p>Market-cap context also matters. At Rs 11,998.48 crore, the company sits above the sector median market cap in the benchmark set, while remaining below the sector average. That places the stock in a larger part of the healthcare universe, even though the day\u2019s decline is the immediate headline.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sequent_Scientific_VIYASH_Fundamental_Analysis\"><\/span><strong>Sequent Scientific (VIYASH) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 11,998.48 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">71.5x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.06%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.89<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Sequent Scientific Fundamental Analysis starts with valuation. The stock trades at a P\/E of 71.5 and a P\/B of 4.35. ROE is 9.06%, ROCE is 13.1%, EPS is Rs 3.89 and book value is Rs 63.92 per share. Dividend yield is 0. These figures matter because they show a company priced at a meaningful earnings multiple even though profitability ratios are moderate.<\/p>\n<p>For Sequent Scientific Share Price, the valuation picture is important precisely because the supplied dataset does not include revenue, net profit, margin, debt or cash-flow data. The analysis therefore stays anchored to the verified metrics only. That is a more reliable reading than trying to infer a reason for the daily fall from information that was not provided.<\/p>\n<p>In practical terms, the stock appears expensive on earnings versus the broader benchmark, while return ratios sit below some sector norms. That does not create a forecast or recommendation, but it does give context for Sequent Scientific Stock Analysis and for anyone comparing the move with the company\u2019s fundamentals.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">71.5x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.94x to 717.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.71x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.06%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 11,998.48 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 613.53 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,734.53 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Sequent Scientific operates in Healthcare and the Pharmaceuticals &amp; Drugs industry. The benchmark set covers 201 companies, giving a useful frame for Sequent Scientific Share Price and valuation comparison. The company\u2019s P\/E of 71.5 is above the sector median of 30.52 and average of 46.79. Its P\/B of 4.35 is also above the median of 2.71 and slightly above the average of 4.22.<\/p>\n<p>Profitability sits a little softer than the benchmark. ROE of 9.06% is below the sector median of 11.82% and the average of 11.28%. ROCE of 13.1% is slightly below the median of 13.88% and the average of 13.78%. Market capitalisation of Rs 11,998.48 crore is far above the sector median of Rs 613.53 crore, while remaining below the sector average of Rs 13,734.53 crore.<\/p>\n<p>The wider industry also shows a broad valuation spread, with P\/E ranging from 2.94 to 717.81 and P\/B ranging from -11.91 to 27.56. Against that backdrop, the stock sits in a premium valuation zone, which helps explain why readers track Sequent Scientific Share Price alongside sector data rather than in isolation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,58,248.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,25,648.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">78.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,84,891.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,926.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,09,825.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Peer comparison shows Sequent Scientific at a higher earnings multiple than Cipla, Zydus Lifesciences, Dr. Reddy\u2019s Laboratories and Sun Pharma, while still below Divi\u2019s Laboratories and Torrent Pharmaceuticals. Its P\/B of 4.35 is above Cipla and Dr. Reddy\u2019s, close to Zydus Lifesciences, and below Sun Pharma, Divi\u2019s and Torrent.<\/p>\n<p>ROE at 9.06% is below every peer listed in this comparison set. ROCE at 13.1% is also below Sun Pharma, Divi\u2019s, Torrent, Cipla and Zydus Lifesciences, and slightly below Dr. Reddy\u2019s at 13.75%. For Sequent Scientific Stock Analysis, those ratios provide the clearest relative context.<\/p>\n<p>In market-cap terms, Sequent Scientific\u2019s Rs 11,998.48 crore is larger than several peers in the broader set, including Cipla, Zydus Lifesciences, Lupin, Dr. Reddy\u2019s, Mankind Pharma and Aurobindo Pharma, but far below Sun Pharma, Divi\u2019s and Torrent.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Sequent_Scientific\"><\/span><strong>Why Investors Are Watching Sequent Scientific<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Sequent Scientific Share Price fell 5.18% today, closing at Rs 263.8 versus Rs 278.2 previously.<\/li>\n<li>The session opened at Rs 271, reached Rs 271.35 and touched Rs 262.4 before ending near the low.<\/li>\n<li>Market capitalisation stood at Rs 11,998.48 crore, and the stock is classified as a Mid Cap.<\/li>\n<li>P\/E is 71.5, P\/B is 4.35, ROE is 9.06% and ROCE is 13.1%.<\/li>\n<li>In the same industry, the P\/E sits above the median of 30.52 and average of 46.79, while ROE stays below the median of 11.82.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Sequent_Scientific\"><\/span><strong>About Sequent Scientific<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sequent Scientific is classified in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied benchmark set uses the same industry for valuation comparison. That is the main business context available in this update.<\/p>\n<p>The article therefore focuses on the verified market data: the share price movement, the valuation ratios, the profitability metrics and the sector benchmark. That is the most reliable way to read Sequent Scientific Share Price and stock performance from the information supplied today.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Sequent_Scientific_Share_Price_on_Univest\"><\/span><strong>Track Sequent Scientific Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/viyash\/sequent-scientific-ltd-share-price-today\">Sequent Scientific (VIYASH) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Track Sequent Scientific Share Price on Univest for live updates, share price news, fundamental ratios, market cap context and sector comparisons. Univest also helps users review 52-week levels, company overview data and market insights in one place.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Sequent_Scientific_Share_Price_fall_today\"><\/span><strong>Why did Sequent Scientific Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data confirms that Sequent Scientific Share Price fell 5.18% to Rs 263.8 from Rs 278.2. It does not establish a company-specific catalyst, so the move should be read as a verified price event.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sequent_Scientific_Share_Price_Today\"><\/span><strong>What is Sequent Scientific Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Sequent Scientific Share Price Today is Rs 263.8. The stock declined by Rs 14.4 on the day, and the market capitalisation stood at Rs 11,998.48 crore in the latest update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_valuation_metrics_show_for_Sequent_Scientific\"><\/span><strong>What do the valuation metrics show for Sequent Scientific?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Sequent Scientific trades at a P\/E of 71.5 and a P\/B of 4.35. EPS is Rs 3.89, book value is Rs 63.92 and dividend yield is 0, which gives valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Sequent_Scientific_compare_with_sector_benchmarks\"><\/span><strong>How does Sequent Scientific compare with sector benchmarks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;In the same-industry benchmark, Sequent Scientific\u2019s P\/E of 71.5 is above the median 30.52 and average 46.79. Its ROE of 9.06 is below the median 11.82, while ROCE of 13.1 is slightly below the median 13.88.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Sequent_Scientific_compare_with_peers\"><\/span><strong>How does Sequent Scientific compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Compared with peers such as Sun Pharma, Cipla, Zydus Lifesciences and Lupin, Sequent Scientific has a higher P\/E than several names and a lower ROE than all listed peers. That is useful for stock analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Sequent_Scientific_Share_Price_on_Univest\"><\/span><strong>Should investors track Sequent Scientific Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Yes. Univest lets users track Sequent Scientific Share Price alongside market cap, valuation ratios, sector context and stock updates. That makes it easier to follow the latest news and broader performance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sequent Scientific Share Price falls to Rs 263.8. marking a 5.18% fall today. Market cap stands at Rs 11,998.48 crore.<\/p>\n","protected":false},"author":29,"featured_media":219445,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-219448","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["219445"],"rank_math_title":["Sequent Scientific Share Price news after 5.18% decline"],"rank_math_description":["Sequent Scientific Share Price fell 5.18% to Rs 263.8. Read price action, valuation, sector comparison and peer context in this stock news update."],"rank_math_focus_keyword":["Sequent Scientific Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Sequent_Scientific_VIYASH_Share_Price_falls_518_to_Rs_2638_what_moved_the_stock_today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/219448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=219448"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/219448\/revisions"}],"predecessor-version":[{"id":219449,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/219448\/revisions\/219449"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/219445"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=219448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=219448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=219448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}